Atrial Fibrillation: Symptoms, Causes & Treatment

Atrial fibrillation (AF) is a common heart rhythm disorder in which the atria (upper chambers of the heart) beat rapidly and irregularly, out of sync with the ventricles (lower chambers). This prevents the atria from contracting effectively, reducing the amount of blood pumped to the body and allowing blood to pool in the atria, which increases the risk of blood clot formation. These clots may travel to the brain and cause a stroke, making AF a serious condition requiring proper management.

AF is one of the most prevalent arrhythmias worldwide, with incidence rising with age. In the Middle East and Jordan, the prevalence is increasing, particularly among elderly patients and those with underlying heart disease. Symptoms vary widely: some patients experience palpitations, shortness of breath, and fatigue, while others may have no noticeable symptoms and discover their condition during routine screening. AF can be paroxysmal (intermittent episodes), persistent, or permanent.

The good news is that AF is highly manageable through a combination of approaches: anticoagulant medications to prevent strokes, rate or rhythm-control drugs to normalize heartbeat, lifestyle modifications, and when appropriate, catheter ablation—a minimally invasive procedure that restores normal heart rhythm in many patients. Early diagnosis and appropriate treatment significantly reduce the risk of complications and improve quality of life.

Many individuals with atrial fibrillation experience no symptoms ('silent AF'), particularly in early or slow-progressing cases. Symptom severity depends on heart rate, AF duration, and overall cardiac health. In elderly patients and women, symptoms may be subtle or misattributed to general fatigue.

• Palpitations: Sensation of rapid, forceful, or irregular heartbeats in the chest.
• Shortness of breath (dyspnea): Difficulty breathing, especially during exertion or at rest in severe cases.
• Fatigue and general weakness: Due to reduced oxygen and blood delivery to tissues.
• Dizziness or lightheadedness: Syncope (fainting) may occur in severe episodes.
• Chest pain or pressure: May resemble angina, particularly with exertion.
• Elevated resting heart rate: Pulse may exceed 100–160 beats per minute.
• Night sweats and anxiety: Often accompany acute episodes.
• Nausea and vomiting: From reduced blood supply to the gastrointestinal system.
• Insomnia and sleep disturbance: Especially if episodes occur at night.
• Exercise intolerance: Physical capacity is notably reduced.
• Acute symptom exacerbation: Symptoms may develop suddenly and feel frightening.
• Rapid symptom improvement: Most symptoms resolve quickly when normal rhythm returns or heart rate is controlled.

• Structural heart disease: Including heart failure, valvular disease, left ventricular hypertrophy, and congenital heart defects, which alter cardiac structure and electrical conduction.
• Hypertension: Causes stiffening and thickening of atrial walls, predisposing to arrhythmia.
• Thyroid disease (hyperthyroidism): Excess thyroid hormones accelerate heart rate and disrupt electrical stability.
• Obesity: Increases inflammation and cardiac strain; elevates risk of hypertension and diabetes.
• Excessive alcohol consumption: Disrupts the electrical activity of pacemaker cells (SA and AV nodes).
• Sleep apnea: Repeated oxygen desaturations destabilize cardiac rhythm.
• Infection and inflammation: Myocarditis or pericarditis may trigger temporary or permanent AF.
• Genetic factors and age: AF runs in families; risk increases significantly after age 65.

• Advanced age: Risk increases gradually after age 60–65 years.
• Male sex: Men have higher AF incidence in younger years; women may experience more severe symptoms post-menopause.
• Diabetes: Diabetic patients have 1.5–2 times higher AF risk.
• Chronic kidney disease: Affects electrolyte balance and systemic inflammation.
• Chronic lung disease and COPD: Reduce oxygen levels and increase cardiac strain.
• Morbid obesity: Increases inflammation and mechanical heart stress.
• Family history: First-degree relatives with AF carry higher genetic risk.
• Smoking: Causes cardiac inflammation and oxidative stress.
• Excessive caffeine and stimulant use: May trigger AF episodes in susceptible individuals.
• Intense endurance athletics: Prolonged high-intensity exercise increases AF risk in some athletes.

Early and accurate diagnosis of AF is essential to prevent complications, especially stroke. Diagnosis involves clinical examination, laboratory tests, and specialized cardiac investigations. The physician typically begins with a thorough history and physical examination, followed by confirmatory tests.

• Electrocardiogram (ECG): The gold-standard diagnostic test. Shows characteristic findings: absent P waves replaced by fine oscillations (f waves), and irregularly irregular RR intervals. ECG must be recorded during an episode for definitive diagnosis.
• Holter monitor (24–72 hours) or extended event recorder: Captures paroxysmal AF episodes that may not appear on a single ECG.
• Stress testing: Assesses heart response to exercise and detects exercise-induced AF.
• Blood tests: Serum electrolytes (K+, Mg2+, Ca2+)—electrolyte abnormalities precipitate AF. Thyroid function tests (TSH, Free T4) since hyperthyroidism is a major trigger. CBC, liver and kidney function (BUN, Creatinine).
• Chest X-ray: Assesses cardiac silhouette, lung congestion, and excludes pulmonary disease.
• Echocardiogram: Evaluates cardiac structure and valves, measures atrial dimensions, assesses left ventricular ejection fraction (LVEF). Normal LVEF: 50–70%.
• Cardiac MRI or CT: May be indicated for tissue characterization or structural evaluation in select cases.
• Electrophysiology study (EPS): Often performed before catheter ablation to precisely localize arrhythmia sources.

Medications

• Anticoagulants: Prescribed to prevent stroke and thromboembolic events in most AF patients (except low-risk groups). Options include warfarin (requires INR monitoring) and direct-acting anticoagulants (DOACs) such as apixaban, rivaroxaban, dabigatran, and edoxaban (no routine monitoring needed).
• Rate-control drugs: Slow heart rate without attempting rhythm restoration. Include beta-blockers (metoprolol, atenolol), calcium-channel blockers (verapamil, diltiazem), and digoxin (especially in HF patients).
• Rhythm-control drugs: Attempt to restore and maintain normal sinus rhythm. Include antiarrhythmic medications: Class I (quinidine, procainamide), Class II/III (amiodarone, sotalol), and flecainide.
• Adjunctive therapies: ACE inhibitors or ARBs reduce blood pressure and cardiac remodeling in patients with concurrent hypertension or heart failure, decreasing AF recurrence.

Procedures and Interventions

• Catheter ablation: Minimally invasive procedure performed under sedation. Catheters are advanced via femoral or neck vessels to the heart. Radiofrequency (RF), cryoablation, or laser energy ablates tissues triggering ectopic activity, particularly around pulmonary vein ostia. Success rates: 60–90% depending on AF type and operator experience.
• Electrical cardioversion: Used for acute, hemodynamically unstable AF. Safe electrical shock synchronized to QRS complex restores normal rhythm immediately. Performed under brief anesthesia.
• Pacemaker implantation: Indicated if AF is complicated by severe bradycardia requiring permanent pacing.
• Implantable cardioverter-defibrillator (ICD): Recommended for AF patients with severe heart failure and reduced LVEF (≤35%).

Lifestyle Modifications and Supportive Measures

• Trigger avoidance: Eliminate caffeine, alcohol, tobacco, stimulants, and recreational drugs; reduce sodium intake.
• Weight management: Losing excess weight reduces cardiac strain and improves AF control.
• Moderate aerobic exercise: Walking, swimming, and yoga are safe and beneficial. Avoid intense competitive sports.
• Stress and anxiety management: Use relaxation, meditation, and behavioral therapy; psychological stress triggers AF episodes.
• Adequate, regular sleep: Sleep deprivation and sleep apnea exacerbate AF.
• Comorbidity management: Optimize control of diabetes, hypertension, and thyroid disease.
• Medication adherence: Take medications exactly as prescribed; never discontinue without physician guidance.
• Regular follow-up: See a cardiologist every 3–6 months for monitoring and treatment adjustment.
• Patient education: Understanding the condition and recognizing warning signs improve self-management.

• Stroke (Cerebrovascular Accident): The most serious complication. AF increases stroke risk 4–5 fold compared to non-AF individuals. Strokes cause paralysis, speech loss, and death. This is the primary indication for anticoagulation therapy in most AF patients.
• Heart failure: Persistent rapid AF reduces cardiac output, leading to progressive systolic or diastolic dysfunction. Presents with dyspnea, lower-limb edema, and fatigue.
• Peripheral thromboembolism: Clots may lodge in peripheral arteries, spleen, or kidneys, causing severe pain and potentially limb loss.
• Acute coronary syndrome: Especially in patients with underlying coronary artery disease. Rapid AF increases myocardial oxygen demand and reduces supply, triggering angina or MI.
• Ventricular fibrillation and sudden cardiac death: Rare but life-threatening, particularly with severe underlying cardiac disease.
• Vascular cognitive impairment and dementia: Recurrent strokes (including silent ones) cause progressive memory loss and cognitive decline.
• Reduced quality of life, anxiety, and depression: Persistent symptoms, fear of episodes, and stroke risk significantly impact mental health and social functioning.
• Bleeding (with anticoagulation): Patients on anticoagulants face increased risk of GI or intracranial hemorrhage, particularly with inadequate monitoring.

• Blood pressure management: Maintain BP <130/80 mmHg significantly reduces AF risk. Adhere to antihypertensive medications and limit sodium intake.
• Maintain healthy weight: Obesity is a strong risk factor. Weight loss of 5–10% may substantially reduce AF episodes.
• Regular moderate aerobic exercise: 150 minutes weekly of moderate-intensity activity (brisk walking, swimming) improves cardiac health and reduces AF risk.
• Avoid alcohol and smoking: Excessive alcohol and nicotine are strong AF triggers. Abstinence or strict reduction is essential.
• Limit caffeine and stimulants: Some individuals are caffeine-sensitive. Minimize intake of coffee, energy drinks, and stimulant medications.
• Stress management and anxiety reduction: Chronic stress is a known trigger. Meditation, yoga, and psychological counseling reduce risk.
• Adequate, regular sleep (7–9 hours daily): Sleep deprivation and sleep apnea significantly increase AF risk. Diagnose and treat sleep disorders.
• Diabetes management: Diabetic patients have elevated AF risk. Good glycemic control reduces incidence.
• Thyroid disease screening and treatment: Hyperthyroidism is a recognized trigger. Thyroid function testing and appropriate treatment are vital.
• Regular medical follow-up: Especially for those with risk factors. Periodic ECG and echocardiography can detect early AF before complications develop.